Lubio Science
VC Fund
Zurich, Switzerland
Lubio Science is a VC fund in Zurich focused on Therapeutics and Biotechnology. Founded in 2004, LubioScience is Switzerland’s fastest-growing distributor of life science reagents. With over 20 years’ experience, LubioScience is the preferred business solution partner of the Swiss Biotech Association, working with researchers within prestigious academia, pharma and biotechnology companies across Switzerland, including ETH Zurich, Roche and Novartis. As a trusted life science supplier, LubioScience is present on all major e-procurement platforms within Switzerland, reaching over 7,000 researchers from multiple sectors. LubioScience is highly regarded among the life science market, present at all prominent trade shows and invited to exhibit within influential life science companies and universities. With an experienced, multi-lingual team, including a PhD-educated sales team, LubioScience holds a high level of technical competence, with a focus on creating positive customer relationships and offering excellent service. As an active distribution partner, LubioScience has a strong presence across a wide variety of marketing channels, launching new products effectively into the market and amplifying supplier brands. Representing over 120 brands, LubioScience offers a broad product portfolio, covering all research areas and applications, with a dedicated business unit for custom services. LubioScience aims to develop strong collaborative relationships with its suppliers and as such, is responsible for the management of European and global supply centres for several suppliers. As a member of Europa Biosite, LubioScience offers a high performance gateway into the Swiss life science market.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Lubio Science invests in
Stages Lubio Science invests in
Countries Lubio Science invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Roland Schärli
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Tobias Dietschy
Marketing & Sales Director
|
Marketing & Sales Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| The company is based on the original discovery that leukemic stem cells in patients with chronic myeloid leukemia (CML) express a cell-surface receptor, whereas corresponding normal hematopoietic stem cells do not express this receptor. Stem cells from patients with acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL) has also beenshown to have and upregulation of the receptor. Cantargia uses this receptor, the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia | $1M / Venture - Series Unknown / Jul 05, 2013 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Lubio Science invest in?
Lubio Science invests primarily in Therapeutics, Biotechnology and Medical Device startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Lubio Science?
Public channels for Lubio Science include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Lubio Science?
The team at Lubio Science includes Roland Schärli (Managing Director) and Tobias Dietschy (Marketing & Sales Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!